Novartis AG 20-F for FY2019

Headline figures

Fiscal year ended December 31, 2019, as reported in this filing, compared with the same period a year earlier where the filing states it.

Net income

$11.73B

down 7.0% from net income of $12.61B a year earlier

Diluted EPS

$5.06

down 5.9% from $5.38 a year earlier